Paid Clinical Trials Stamford
Discover 973 paid clinical trials in Stamford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sustained Acoustic MedicineSustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Sponsor:
ZetrOZ, Inc.
Location:
Code:
NCT06257537
Conditions
Osteo Arthritis Knee
Arthritis
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Accepted
Interventions
Sustained Acoustic Device with 2.5% Diclofenac Patch
Sustained Acoustic Device with 0% Diclofenac Patch
2.5% Diclofenac Patches
SAM Patch
Pembrolizumab & Sacituzumab TirxumotecanA Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06312137
Conditions
Non Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab tirumotecan
Pembrolizumab
Cisplatin
Pemetrexed
Gemcitabine
STOP Persistent AFSTOP Persistent AF PAS
Sponsor:
Medtronic Cardiac Ablation Solutions
Location:
Code:
NCT05005949
Conditions
Persistent Atrial Fibrillation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Arctic Front™ Cardiac Cryoablation Catheter System
ValbenazineStudy to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
Sponsor:
Neurocrine Biosciences
Location:
Code:
NCT05206513
Conditions
Dyskinesia
Cerebral Palsy
Eligibility Criteria
Sex: All
Age: 6 - 70
Healthy Volunteers: Not accepted
Interventions
Placebo
Valbenazine
Detoxification with MedicationDetoxification and Treatment of Subjects With Medication Overuse Headache
Sponsor:
The New England Center for Headache, P.C.
Location:
Code:
NCT00432549
Conditions
Analgesic Rebound Headache
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Almotriptan
Topiramate
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ianalumab & Standard-of-CarePhase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT05639114
Conditions
Systemic Lupus Erythematosus
Eligibility Criteria
Sex: All
Age: 12 - 70+
Healthy Volunteers: Not accepted
Interventions
Ianalumab
Placebo
HER2 LowQuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
Sponsor:
Angela DeMichele
Location:
Code:
NCT06551116
Conditions
HER2-positive Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CE-10-IVD
TAP BlocksMedial Versus Traditional Approach to US-guided TAP Blocks for Open Inguinal Hernia Repair
Sponsor:
Stamford Anesthesiology Services, PC
Location:
Code:
NCT01589796
Conditions
Abdominal Muscles/Ultrasonography
Adult
Ambulatory Surgical Procedures
Anesthetics, Local/Administration & Dosage
Ropivacaine/Administration & Dosage
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
TAP block
EptinezumabA Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Sponsor:
H. Lundbeck A/S
Location:
Code:
NCT05164172
Conditions
Migraine
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Interventions
Eptinezumab
Remibrutinib vs. TeriflunomideEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT05156281
Conditions
Relapsing Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
Remibrutinib
Teriflunomide